Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 596 participants.

Also called NCT03519737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 596 participants (planned count) (from the registry)
Sponsor
Cerevast Medical, Inc. (from the registry)
Registry
  • NCT NCT03519737
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03519737. Randomized; quadruple masking; primary purpose treatment. Start 2018-08-17 (actual); primary completion 2021-11-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aureva Transcranial Ultrasound Device With tPA in Patients With Acute Ischemic Stroke
Acronym
TRUST
Condition
Acute Ischemic Stroke
Intervention (Device)
tPA in combination with the Sonolysis Headframe (TUS)
Intervention (Device)
tPA in combination with the Sonolysis Headframe (Sham TUS)
Lead sponsor
Cerevast Medical, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03519737
Content hash
70b7e5adb103edfb2b53f975cbdd2518ae1e3560302f1bd1f19ce80b18572a5b